These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha). Song J, Markley JL. J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787 [Abstract] [Full Text] [Related]
5. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods. Walkenhorst WF, Krezel AM, Rhyu GI, Markley JL. J Mol Biol; 1994 Sep 23; 242(3):215-30. PubMed ID: 8089843 [Abstract] [Full Text] [Related]
6. Thermodynamics and kinetics of the hydrolysis and resynthesis of the reactive site peptide bond in turkey ovomucoid third domain by aspergillopeptidase B. Ardelt W, Laskowski M. Acta Biochim Pol; 1983 Sep 23; 30(2):115-26. PubMed ID: 6346765 [Abstract] [Full Text] [Related]
7. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics. Song J, Laskowski M, Qasim MA, Markley JL. Biochemistry; 2003 Jun 03; 42(21):6380-91. PubMed ID: 12767219 [Abstract] [Full Text] [Related]
11. [Conformation of the third domain of turkey ovomucoid in solution. Structural analysis by two-dimensional Overhauser nuclear effect spectroscopy]. Andrianov AM. Mol Biol (Mosk); 1991 Jun 03; 25(5):1215-25. PubMed ID: 1753953 [Abstract] [Full Text] [Related]
12. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I. Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M, James MN. J Mol Biol; 2001 Jan 26; 305(4):839-49. PubMed ID: 11162096 [Abstract] [Full Text] [Related]
14. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain. Lu W, Qasim MA, Laskowski M, Kent SB. Biochemistry; 1997 Jan 28; 36(4):673-9. PubMed ID: 9020764 [Abstract] [Full Text] [Related]
15. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain. Qasim MA, Van Etten RL, Yeh T, Saunders C, Ganz PJ, Qasim S, Wang L, Laskowski M. Biochemistry; 2006 Sep 26; 45(38):11342-8. PubMed ID: 16981694 [Abstract] [Full Text] [Related]
16. Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations. Maynes JT, Cherney MM, Qasim MA, Laskowski M, James MN. Acta Crystallogr D Biol Crystallogr; 2005 May 26; 61(Pt 5):580-8. PubMed ID: 15858268 [Abstract] [Full Text] [Related]